Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

33.3%

2 terminated/withdrawn out of 6 trials

Success Rate

60.0%

-26.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT03953846Terminated

NUsurface Implant Registry

Role: lead

NCT02483988Not ApplicableUnknown

The SUN Clinical Trial (Safety Utilizing NUsurface Meniscus Implant)

Role: lead

NCT01712191Not ApplicableCompleted

Treatment of the Medial Meniscus With the NUsurface(R) Meniscus Implant

Role: lead

NCT02108496Not ApplicableCompleted

Verifying the Effectiveness of the NUsurface® System

Role: lead

NCT02136901Not ApplicableCompleted

The VENUS Clinical Study (Verifying the Effectiveness of the NUsurface® System)

Role: lead

NCT00663468Terminated

Treatment of Sub-capital Fractures of Hip Joint by Using TriboFit™ Acetabular Buffer

Role: lead

All 6 trials loaded